Nyctea Technologies brings electrified purification to drug development to accelerate medical innovation
Founded at Chalmers University and funded by Chalmers Ventures, Nyctea Technologies uses its proprietary electrification and digitalization technology to purify biopharmaceuticals effectively and efficiently. This enables pharmaceutical companies to bring safe medication to patients faster, helping societies tackle increasing health issues such as cancer and Alzheimer’s.Gothenburg, Sweden (December 3rd, 2024) Swedish deeptech and medtech startup Nyctea Technologies is gearing up toward market expansion with its patented biomolecular purification technology.